Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2020
New Titles 2019
Price and Ordering Information
Subscription Rates 2020
Subscription Rates 2019
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Bentham Online
Accessibility Of Content
Bentham Insight
Online Feedback
Purchase Articles
Search Articles
Social Media
Submit Manuscripts
Marketing Opportunities
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2019
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Kudos
Media Partners
Partnering Events
Promotional Services
For Librarians
FAQs for e-prints/reprints
Journal Catalog 2019
Journal Catalog 2020
Library Recommendations
Order Bulk ePrints
Order Bulk Reprints
Table of Contents Alert
Trial Requests
For Authors & Editors
Author Benefits
Author Reprints
Author's Benefits Guide
Copyediting Services
Editorial Policies
General FAQs
Guidelines for Guest Editors
Manuscript Transfer Facility
Online Manuscript Submission
Journal Catalog 2019
Journal Catalog 2020
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Contact Us
Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.72
5 Year Impact Factor:
3.238
Ranking and Category
135
th
of
229
in
Oncology
Order Your Article Before Print
Join as Executive Guest Editor
Become a Reviewer
Join Editorial Board
Submit Book Proposal
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 16
- Number 4
Editorial
Open Access
Meet Our Editorial Board Member:
,
16
(
4
):
287
Evan Keller
DOI:
10.2174/156800961604160408203704
View Editorial
Permissions
Download Free
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
,
16
(
4
):
288
- 304
Zhipeng Zou, Juan Chen, Jun Yang and Xiaochun Bai
DOI:
10.2174/1568009616666151113120830
×
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
A New Therapeutic Era in GCB and ABC Diffuse Large B-cell Lymphom a Molecular Subtypes: A Cell of Origin-Driven Review
,
16
(
4
):
305
- 322
Jose D. Sandoval-Sus, Julio Chavez and Samir Dalia
DOI:
10.2174/1568009615666151030102539
×
A New Therapeutic Era in GCB and ABC Diffuse Large B-cell Lymphom a Molecular Subtypes: A Cell of Origin-Driven Review
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
New Insights into the Molecular Resistance Mechanisms of Chronic Myeloid Leukemia
,
16
(
4
):
323
- 345
Rui Huang, Qian Kang, Huimin Liu and Yuhua Li
DOI:
10.2174/1568009615666150921141004
×
New Insights into the Molecular Resistance Mechanisms of Chronic Myeloid Leukemia
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
,
16
(
4
):
346
- 356
Xue-Qing Hu, Yang Sun, Eric Lau, Ming Zhao and Shi-Bing Su
DOI:
10.2174/1568009616666151207105851
×
Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer
,
16
(
4
):
357
- 372
Niladri Shekhar Dey, Biswajit Mukherjee, Ruma Maji and Bhabani Sankar Satapathy
DOI:
10.2174/1568009616666151106120606
×
Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines
,
16
(
4
):
373
- 385
Alessio Papi, Marzia Govoni, Carmen Ciavarella, Enzo Spisni, Marina Orlandi and Fulvia Farabegoli
DOI:
10.2174/1568009615666150817120931
×
Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines
View Abstract
中文摘要
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
中文摘要
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Reviewer Board
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Self-Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2019
⇨ Journal Catalog 2020
⇨ Most Accessed Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Scopus CiteScore Metrics:
2.26
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2019 Bentham Science
|
Privacy Policy